Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.25 and last traded at C$0.27, with a volume of 351405 shares. The stock had previously closed at C$0.26.
Nanalysis Scientific Stock Down 3.3 %
The company has a quick ratio of 1.11, a current ratio of 1.42 and a debt-to-equity ratio of 71.72. The company’s 50 day moving average price is C$0.34 and its 200 day moving average price is C$0.39. The firm has a market capitalization of C$33.35 million, a price-to-earnings ratio of -2.46 and a beta of 0.72.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Featured Stories
- Five stocks we like better than Nanalysis Scientific
- What is the NASDAQ Stock Exchange?
- Micron Stock Under $100: Seize the AI-Driven Upside
- Investing in Construction Stocks
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What Are Dividend Champions? How to Invest in the Champions
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
